CT-5172

CT-5172
Clinical data
Other names	CT5172; 2,6-Dimethoxy-3,5-dichlorophenethylamine
Drug class	Serotonergic psychedelic; Hallucinogen
ATC code	None;
Identifiers
	IUPAC name 2-(2,6-dimethoxy-3,5-dichlorophenyl)ethanamine;
Chemical and physical data
Formula	C10H13Cl2NO2
Molar mass	250.12 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1C(Cl)=CC(Cl)=C(OC)C=1CCN([H])[H];
	InChI InChI=1S/C10H13Cl2NO2/c1-14-9-6(3-4-13)10(15-2)8(12)5-7(9)11/h5H,3-4,13H2,1-2H3; Key:JROHWNOMPJKXNY-UHFFFAOYSA-N;

CT-5172, also known as 2,6-dimethoxy-3,5-dichlorophenethylamine, is a claimed hallucinogen of the phenethylamine family. It is an analogue of the serotonergic psychedelics mescaline and the 2C series but with an unusual substitution pattern on the benzene ring that includes methoxy groups at the 2 and 6 positions and chlorine atoms at the 3 and 5 positions. The drug was reported to have significant but relatively weak mescaline-like effects in cats. CT-5172 was first described in the scientific literature by 1969. Various related analogues, such as CT-5126 and CT-4719, have also been described. CT-5172 and related compounds were developed at the Laboratoire de Chimie Thérapeutique (CT; Therapeutic Chemistry Laboratory) of the Pasteur Institute in Paris, France.